Author(s)

Wenyu Qin, Bao He, Yu Bei, Rushang Wang, Lang Feng, Youhua Xu, Jiaxiao Zhu, Zhaoguang Zheng, Quan Zhu, Hong Nie

1Jinan University College of Pharmacy, Guangzhou, China; 2Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou, China;.
3Institute of Conson Co. for Chinese Medicine in Kidney Diseases, Consun Pharmaceutical Group, Guangzhou, China; 4Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China..
Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, China.
Institute of Conson Co. for Chinese Medicine in Kidney Diseases, Consun Pharmaceutical Group, Guangzhou, China.
Jinan University College of Pharmacy, Guangzhou, China.

Advanced glycation end products (AGEs) have been regarded as a pivotal inducer in diabetes and kinds of diabetic nephropathy. The present studies explored the effects of Danggui Buxue Tang (DBT) that is a Chinese medicinal de- coction on negative charge to Human Umbilical Vein Endothelial Cell (HUVEC) and the related mechanism. Alcian blue staining was established to evaluate the intensity of negative charge on HUVEC. Proteoglycan expressions of AGP and avidin were determined by SDS-PAGE. We observed that DBT can significantly increase negative charge on HU-VEC and up-regulated AGP and avidin expressions and ameliorate AGEs-induced HUVEC apoptosis. Therefore, all results showed DBT had prevention effects against the progression of AGEs-induced damage, and this decoction might be promising agent against proteinuria in diabetic nephropathy.

Danggui Buxue Tang (DBT); AGEs; Negative Charge; Apoptosis; Proteinuria; Diabetic Nephropathy

W. Qin, B. He, Y. Bei, R. Wang, L. Feng, Y. Xu, J. Zhu, Z. Zheng, Q. Zhu and H. Nie, "Protective Effects of Danggui Buxue Tang on a Human Umbilical Vein Endothelialcell Damage Induced by Advanced Glycation End Products," Pharmacology & Pharmacy, Vol. 3 No. 2, 2012, pp. 224-233. doi: 10.4236/pp.2012.32030.